Real-world evidence supporting sustainable CAR-T-cell therapy—from access to long-term follow-up

Tomoyasu Jo

Open source

DOI
10.1007/s12185-026-04305-z
Published
2026-11-02
Container
International Journal of Hematology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12185-026-04305-z,
  title = {Real-world evidence supporting sustainable CAR-T-cell therapy—from access to long-term follow-up},
  author = {Tomoyasu Jo},
  year = {2026},
  journal = {International Journal of Hematology},
  doi = {10.1007/s12185-026-04305-z},
  url = {https://doi.org/10.1007/s12185-026-04305-z}
}

RIS

TY  - JOUR
TI  - Real-world evidence supporting sustainable CAR-T-cell therapy—from access to long-term follow-up
AU  - Tomoyasu Jo
PY  - 2026
JO  - International Journal of Hematology
DO  - 10.1007/s12185-026-04305-z
UR  - https://doi.org/10.1007/s12185-026-04305-z
ER  - 

APA

Jo, T. (2026). Real-world evidence supporting sustainable CAR-T-cell therapy—from access to long-term follow-up. International Journal of Hematology. https://doi.org/10.1007/s12185-026-04305-z

Source records